|
|
|
Volumn 45, Issue 1169, 2003, Pages 90-92
|
|
Atazanavir (Reyataz)and emtricitabine (Emtriva) for HIV infection
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIRETROVIRUS AGENT;
ATAZANAVIR;
DEOXYCYTIDINE;
DRUG DERIVATIVE;
EMTRICITABINE;
OLIGOPEPTIDE;
PYRIDINE DERIVATIVE;
ARTICLE;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DOSE RESPONSE;
DRUG EFFECT;
DRUG INTERACTION;
DRUG RESISTANCE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
JAUNDICE;
PHYSIOLOGY;
RANDOMIZED CONTROLLED TRIAL;
ANTI-RETROVIRAL AGENTS;
DEOXYCYTIDINE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG INTERACTIONS;
DRUG RESISTANCE;
HIV INFECTIONS;
HIV-1;
HUMANS;
JAUNDICE;
OLIGOPEPTIDES;
PYRIDINES;
RANDOMIZED CONTROLLED TRIALS;
|
|
EID: 0642310393
PISSN: 0025732X
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
|
Times cited : (3)
|
|
References (0)
|